Voya Investment Management LLC Theravance Biopharma, Inc. Transaction History

Voya Investment Management LLC

$86.1 Billion
Q1 2024

A detailed history of Voya Investment Management LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 17,964 shares of TBPH stock, worth $152,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,964

Previous 24,036 25.26%

Holding current value

$152,334

Previous $270,000 40.37%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$8.22 - $11.59 $49,911 - $70,374	-6,072 Reduced 25.26%	17,964 $161,000
Q4 2023 Feb 14, 2024	SELL	$8.58 - $11.4 $21,347 - $28,363	-2,488 Reduced 9.38%	24,036 $270,000
Q2 2023 Aug 14, 2023	BUY	$10.16 - $11.92 $5,842 - $6,854	575 Added 2.22%	26,524 $274,000
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $11,813 - $14,389	1,408 Added 5.74%	25,949 $263,000
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $137,881 - $169,524	-16,395 Reduced 40.05%	24,541 $222,000

Q1 2022 May 16, 2022	SELL	$8.33 - $12.96 $2,182 - $3,395	-262 Reduced 0.64%	40,936 $391,000
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $148,169 - $220,657	19,969 Added 94.06%	41,198 $455,000
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $1,543 - $3,285	228 Added 1.09%	21,229 $157,000
Q2 2021 Aug 16, 2021	SELL	$14.52 - $22.46 $8,915 - $13,790	-614 Reduced 2.84%	21,001 $305,000
Q1 2021 May 17, 2021	BUY	$16.57 - $21.08 $26,677 - $33,938	1,610 Added 8.05%	21,615 $441,000
Q4 2020 Feb 16, 2021	BUY	$14.89 - $20.16 $45,593 - $61,729	3,062 Added 18.07%	20,005 $355,000
Q2 2020 Aug 14, 2020	SELL	$20.64 - $30.69 $143,282 - $213,049	-6,942 Reduced 29.06%	16,943 $356,000
Q1 2020 May 15, 2020	BUY	$17.84 - $31.21 $47,329 - $82,800	2,653 Added 12.5%	23,885 $552,000
Q4 2019 Feb 14, 2020	BUY	$16.12 - $25.89 $38,720 - $62,187	2,402 Added 12.76%	21,232 $550,000
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $13,977 - $22,534	896 Added 5.0%	18,830 $307,000
Q1 2019 May 15, 2019	SELL	$22.57 - $28.15 $13,158 - $16,411	-583 Reduced 3.15%	17,934 $407,000
Q4 2018 Feb 14, 2019	BUY	$22.52 - $35.07 $21,213 - $33,035	942 Added 5.36%	18,517 $474,000
Q2 2018 Aug 14, 2018	SELL	$22.06 - $25.52 $30,332 - $35,090	-1,375 Reduced 7.26%	17,575 $399,000
Q3 2017 Nov 14, 2017	BUY	$23.88 - $34.96 $452,526 - $662,492	18,950	18,950 $649,000

Others Institutions Holding TBPH

# of Institutions

124

Shares Held

49.6M

Call Options Held

1.4K

Put Options Held

2.3K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $566M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Theravance Biopharma, Inc. Transaction History